EGFR and breast cancer: Similarly, a significant increase in the colocalization of GFP and p‐EGFR (activated EGFR) was observed in the CD24−/CD44+‐breast CSC as compared with the CD24+‐breast cancer cell xenotransplanted groups (Figure 6A).